The clinical nurse educator working in the adjacent lab was called to assist and made the decision to use the LUCAS 2 mechanical chest compression device to provide automatic external chest compressions. The radiolucent carbon fiber backboard was placed under Vanessa’s shoulders and the piston/suction cup placed over her chest. Once started, the LUCAS 2 applied continuous chest compressions of at least 5 centimeters at a consistent rate of 100 or more compressions per minute.

After several years of trials and increasing clinical use, transcatheter aortic valve replacement (TAVR) has reached a tipping point. It is quickly becoming the standard of care for ill patients suffering from aortic valve stenosis who are not eligible for open heart surgery. Implemented successfully, TAVR procedures improve outcomes and quality of life for patients while reducing costs for hospitals. 

Covidien TurboHawk Clinical Study Directional Atherectomy Effective PAD Therapy

Directional atherectomy is safe and effective as a frontline therapy for the treatment of peripheral arterial disease (PAD), according to a landmark Covidien study published online in the Journal of American College of Cardiology, Cardiovascular Interventions (JACC CI).

St. John Hospital currently performs about 2,000 percutaneous coronary and peripheral interventions and 400 open-heart surgeries, including minimally invasive and robotic surgery. With a goal to create a full structural heart program that answers its patients many needs, St. John Hospital recently created a hybrid operating room (OR). Among the challenges were deciding where to put the room, what procedures would be performed and what equipment would be necessary.

 

The U.S, Food and Drug Administration (FDA) has cleared MicroVention Inc.’s Low-Profile Visualized Intraluminal Support Device (LVIS and LVIS Jr.), which is a stent and delivery system used to treat certain brain aneurysms.

September 5, 2014 — The number of uninsured is expected to decline by nearly half from 45 million in 2012 to 23 million by 2023 as a result of the coverage expansions associated with the Affordable Care Act (ACA), according to a report from the Centers for Medicare & Medicaid Services (CMS) Office of the Actuary. The report is published in Health Affairs.

September 5, 2014 — CardiacAssist announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new Protek Duo veno?venous cannula. The Protek Duo is intended for use as a single cannula for both venous drainage and reinfusion of blood via an internal jugular vein during extracorporeal life support (ECLS) procedures.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now